Appen (ASX: APX) – Appen Files Interim Financial Report
Appen Limited has reported a significant improvement in profitability for the half-year ended 30 June 2026, with loss from ordinary activities...
Appen Limited has reported a significant improvement in profitability for the half-year ended 30 June 2026, with loss from ordinary activities...
Mesoblast Limited has delivered a striking financial inflection, reporting total revenue of US$120.3 million for the financial year ended June 30,...
Mesoblast Limited has delivered a significant commercial milestone with Ryoncil, the first-in-class FDA-approved mesenchymal stem cell therapy,...
Qantas Airways has reported full-year results for the 12 months to 30 June 2026 that reveal a company navigating challenging operating conditions....
Smartgroup has reported solid first-half results that demonstrate the salary packaging specialist is translating market tailwinds into both revenue...